Avantor® Welcomes Gregory T. Lucier as New Board Member to Enhance Leadership

Avantor® Welcomes Gregory T. Lucier as New Board Member

Avantor, Inc. has made headlines with the significant addition of Gregory T. Lucier to its Board of Directors, aiming to leverage his vast experience in the life sciences industry. Mr. Lucier’s appointment comes at a crucial time as Avantor continues to focus on expanding its operations and delivering sustainable shareholder value.

With a career that spans over three decades, Mr. Lucier has made a name for himself as a leader in the healthcare sector. His rich background includes serving as the Executive Chairman and CEO of Corza Medical, a company renowned for manufacturing cutting-edge surgical technologies and medical device components. Additionally, he holds the position of Chairman of Dentsply Sirona and has been a board member of Maravai LifeSciences. Previously, Lucier has taken charge as the Chairman and CEO of both NuVasive and Life Technologies, showcasing a strong trajectory of leadership and innovation.

Jonathan Peacock, the Chairman of Avantor's Board, expressed excitement regarding Mr. Lucier's arrival, acknowledging his proven ability to drive growth and foster innovation. "Greg has a tremendous track record throughout his career in the Life Sciences sector. We are eager to benefit from the invaluable insights he brings to our Board as we unlock Avantor's potential and enhance our profitability across Lab Solutions and Bioscience Production," Peacock stated.

In an expression of his vision for Avantor, Mr. Lucier reaffirmed that the company is well-positioned for sustained industry leadership and long-term value creation. His collaborative approach in working alongside talented teams of executives has been instrumental in capitalizing on growth opportunities within the healthcare market. Lucier’s proactive and strategic insights are anticipated to strengthen Avantor’s platform further, advancing its mission of delivering impactful solutions in the science and technology domains.

Mr. Lucier founded Corza Medical in 2021, collaborating with GTCR, a prominent private equity firm, to establish a strong foothold in the surgical technologies market. His previous tenure at NuVasive from 2015 to 2021 further exemplifies his commitment to healthcare innovation, particularly in the realms of minimally invasive surgery. Moreover, his leadership at Life Technologies led to the impressive growth of Invitrogen, a mid-size life sciences enterprise, which Mr. Lucier guided to over $4 billion in sales. The successful sale of Life Technologies to Thermo Fisher Scientific in 2014 stands as a testament to his strategic acumen.

Mr. Lucier’s educational background complements his impressive career; he holds a degree in industrial engineering from Pennsylvania State University and an MBA from Harvard Business School, equipping him with both technical and managerial expertise.

About Avantor

Avantor® is recognized as a leading life science tools company, delivering mission-critical products and services to its clients across the life sciences and advanced technology sectors. By focusing on collaboration with customers, Avantor enables breakthroughs in diverse fields, including medicine and healthcare. With a presence at over 300,000 customer locations across 180 countries, Avantor is pivotal in driving innovation through its extensive product portfolio.

As Avantor embarks on this new chapter in its leadership dynamics, the company looks forward to leveraging Mr. Lucier's expertise in navigating challenges and creating opportunities in the evolving landscape of life sciences.